You are here: Industry Insights > lupin

News List

Lupin gets UK marketing authorisation for Luforbec 100/6 µg pMDI expresspharma
June 16, 2021
Luforbec 100/6 µg pMDI is indicated for regular treatment of asthma and for the symptomatic treatment of patients with severe COPD.
Lupin donates oxygen generation plants in Maharashtra, MP and Gujarat expresspharma
June 15, 2021
Lupin, through its CSR arm, the Lupin Foundation, is donating five oxygen generation plants to assist the states of Maharashtra, Madhya Pradesh and Gujarat.
Lupin gets USFDA nod to market generic HIV drug expresspharma
June 08, 2021
The company has received approval from the United States Food and Drug Administration (USFDA) to market its emtricitabine and tenofovir disoproxil fumarate tablets, 200 mg/300 mg, Lupin said in a regulatory filing.
Lupin launches generic version of Brovana in US expresspharma
June 04, 2021
Lupin announced the launch of the authorised generic version of Brovana (arformoterol tartrate) Inhalation Solution 15 mcgꝉ/2 mL, unit-dose vials, of Sunovion Pharmaceuticals.
US FDA accepts biologics license application from Lupin for pegfilgrastim biosimilar expresspharma
June 03, 2021
Lupin announced that the US FDA has accepted the Biologics License Application (BLA) for its proposed biosimilar to Neulasta (pegfilgrastim) through a filing using the 351(k) pathway.
Lupin announces achievement of key milestones for its clinical stage MEK inhibitor compound expresspharma
May 31, 2021
Lupin’s MEK inhibitor compound is planned for clinical development in combination with Boehringer Ingelheim’s KRAS inhibitor pipeline to address KRAS-driven cancers.
Lilly signs licensing agreements with Cipla, Lupin and Sun Pharma for Baricitinib in India expresspharma
May 11, 2021
Eli Lilly and Company announced that it has issued royalty-free, non-exclusive voluntary licenses to established Indian pharmaceutical manufacturers of generic medicines, Cipla, Lupin and Sun Pharmaceutical Industries, who are collaborating with Lilly ...
Lupin, Sun Pharma, Jubilant Cadista recall generic medicines in US expresspharma
April 26, 2021
Lupin is recalling 17,814 bottles of Cefprozil, Sun Pharma is recalling 13,834 bottles of Riomet and Jubilant Cadista Pharmaceuticals is recalling 12,192 bottles of Itraconazole capsules.
Four pharma majors invest in ABCD Technologies expresspharma
March 26, 2021
Drug majors Sun Pharma, Lupin, Cadila Healthcare and Torrent Pharma on Thursday said they have subscribed to partnership interest in healthcare services firm ABCD Technologies which will be renamed as IndoHealth Services.
Lupin launches Nitazoxanide Tablets expresspharma
March 11, 2021
They are indicated in the treatment of diarrhoea caused by Giardia lamblia or Cryptosporidium parvum.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 19 20 Next page